Document is current
Any future updates will be listed below
-
Authors
Lundgren, Julie R. https://orcid.org/0000-0002-0761-3008
Færch, Kristine
Witte, Daniel R.
Jonsson, Anna E.
Pedersen, Oluf
Hansen, Torben
Lauritzen, Torsten
Holst, Jens J.
Vistisen, Dorte
Jørgensen, Marit E.
Torekov, Signe S. https://orcid.org/0000-0001-6779-0252
Johansen, Nanna B.
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (DK) Tripartite Immunometabolism Consortium (NNF15CC0018486)
- License Information
-
More Information
Article History
Received: 8 July 2019
Accepted: 27 September 2019
First Online: 5 October 2019
Ethics approval and consent to participate
: The ADDITION-PRO study was approved by the Ethical Committee in the Central Danish Region (No. 20000183). Written informed consents were obtained from all participants prior to the examination.
: Not applicable.
: TL holds shares in Novo Nordisk. All other authors declare that they have no competing interests.
